Recently added

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Wine, Eytan; Aloi, Marina; Van Biervliet, Stephanie; Bronsky, Jiri; Gasparetto, Marco; Martín de Carpi, Javier; Pellino, Gianluca (Wiley, 2025-09)

Development, implementation and evaluation of a digital treatment for adolescents with chronic pain: a protocol for a multi-phase study

Miró, Jordi; Sampietro, Ariadna; Monterde, Sonia; Ingelmo, Pablo; Wicksell, Rikard; Nolla, Carme; Sánchez Torrents, Vanessa (Frontiers Media, 2025-06-04)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models

Lucas-Del-Pozo, Sara; Uras, Giuseppe; Fierli, Federico; Lentini, Veronica; Koletsi, Sofia; Lázaro Hernández, Carlos (Elsevier, 2025-10-15)

The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients

Thielmann, Matthias; Kribben, Andreas; Unglaube, Moritz; Tyczynski, Bartosz; Kreutz, Julian; Ferrer, Ricard (Elsevier, 2025-10)

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Raghav, Kanwal; Pallis, Athanasios; Kopetz, Scott; Boni, Valentina; Kato, Ken; Vieito , Maria (Nature Portfolio, 2025-10)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Development, implementation and evaluation of a digital treatment for adolescents with chronic pain: a protocol for a multi-phase study

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models

The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation ﻿

Development, implementation and evaluation of a digital treatment for adolescents with chronic pain: a protocol for a multi-phase study ﻿

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models ﻿

The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients ﻿

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial ﻿

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Development, implementation and evaluation of a digital treatment for adolescents with chronic pain: a protocol for a multi-phase study

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models

The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial